Equity Market Performance: PXBIX.US invests in biotechnology companies. Broader market sentiment and performance, particularly within the technology and healthcare sectors, influence the fund's value.

Biotech Industry Trends: Advancements, regulatory changes, clinical trial outcomes, and overall investor confidence in the biotechnology industry significantly impact the price.

Interest Rate Changes: Rising interest rates can make growth stocks, common in biotech, less attractive, potentially decreasing the fund's price. Lower rates can have the opposite effect.

Fund Manager Performance: The expertise and strategies employed by the fund's managers in selecting and managing biotech stocks affect returns and thus the price.

Economic Conditions: Economic recessions or expansions can affect investor sentiment and risk appetite, influencing the demand for biotech stocks and impacting the fund's price.

Regulatory Environment: Government regulations regarding drug approvals, pricing, and healthcare policies directly affect the profitability and outlook of biotechnology companies held by the fund.

Company-Specific News: Major announcements from companies within the fund's portfolio, such as FDA approvals, clinical trial results, or mergers and acquisitions, can lead to price fluctuations.